4.7 Article

Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells

Vipul Kumar et al.

Summary: A study examined the binding potential of natural compounds Withaferin-A, Withanone, and caffeic acid phenethyl ester to the cell surface receptor TMPRSS2 using molecular docking and molecular dynamics simulations. The results showed that Withanone had stronger interactions with TMPRSS2 and was able to induce changes in its allosteric site. Furthermore, Withanone downregulated TMPRSS2 mRNA expression, suggesting its potential dual action in blocking SARS-CoV-2 entry into host cells.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Editorial Material Pharmacology & Pharmacy

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro

Nicola Clementi et al.

PHARMACOLOGICAL RESEARCH (2021)

Review Chemistry, Medicinal

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

Choongho Lee et al.

Summary: The novel coronavirus SARS-CoV-2, known as COVID-19, has had a devastating impact on the global economy and healthcare systems, changing the definition of normal life. Developing effective therapeutics and preventive measures is crucial in fighting SARS-CoV-2 infection and restoring normalcy. Understanding COVID-19 pathogenesis is essential in guiding the development of anti-COVID-19 drugs and vaccines.

ARCHIVES OF PHARMACAL RESEARCH (2021)

Letter Oncology

Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein

Satish Sagar et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Medicine, Research & Experimental

Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications

Rishabh Hirawat et al.

Summary: COVID-19 is an unprecedented health crisis with its ease of transmission between humans and undetectability in the early stages making it particularly frightening. Characterized by pneumonia progressing to breathing difficulty, acute respiratory distress syndrome, and multi-organ failure, the excessive release of inflammatory mediators leading to cytokine storm is a potentially life-threatening phenomenon associated with this disease.

LIFE SCIENCES (2021)

Article Cell Biology

Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

Olumayokun A. Olajide et al.

Summary: The study found that SARS-CoV-2 spike glycoprotein S1 stimulated PBMCs to release pro-inflammatory cytokines through mechanisms involving activation of NF-kappa B, p38 MAPK, and NLRP3 inflammasome. The clinical benefits of dexamethasone in COVID-19 may be due to its anti-inflammatory activity in reducing SARS-CoV-2 cytokine storm.

INFLAMMATION (2021)

Article Virology

Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Sheng-Teng Huang et al.

Summary: The study found that extracts from Scutellaria barbata D. Don can inhibit the enzyme activities of M-pro and TMPRSS2, effectively inhibiting SARS-CoV-2 infection through a TMPRSS2-dependent mechanism.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages

Ken Shirato et al.

Summary: Research has shown that the spike protein S1 subunit of SARS-CoV-2 activates TLR4 signaling to induce pro-inflammatory responses in murine and human macrophages, suggesting that TLR4 signaling in macrophages may be a potential target for regulating excessive inflammation in COVID-19 patients.

HELIYON (2021)

Review Immunology

The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients

Apurva Hariharan et al.

Summary: COVID-19 causes a cytokine storm mainly affecting the lungs, with elderly and patients with metabolic syndrome being more susceptible. Immunomodulation targeting NF-kappa B activation and inhibitors can potentially reduce the cytokine storm, alleviating the severity of COVID-19. Inhibition of the NF-kappa B pathway may play a therapeutic role in alleviating severe forms of COVID-19.

INFLAMMOPHARMACOLOGY (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Immunology

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

Toshio Hirano et al.

IMMUNITY (2020)

Review Allergy

JAK Inhibition as a New Treatment Strategy for Patients with COVID-19

Farhad Seif et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)

Letter Chemistry, Medicinal

Cytokine storm in COVID-19 and parthenolide: Preclinical evidence

Mohsen Bahrami et al.

PHYTOTHERAPY RESEARCH (2020)

Letter Virology

Elevated interleukin-6 and severe COVID-19: A meta-analysis

Muhammad Aziz et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Review Medicine, Research & Experimental

Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review

Neda Roshanravan et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Review Immunology

Targeting the NLRP3 Inflammasome in Severe COVID-19

Tracey L. Freeman et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Pharmacology & Pharmacy

A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

Sajad Khiali et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

News Item Multidisciplinary Sciences

STEROID IS FIRST DRUG SHOWN TO PREVENT DEATHS FROM COVID-19

Heidi Ledford

NATURE (2020)

Article Chemistry, Medicinal

Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors

Chau Phi Dinh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Letter Infectious Diseases

Interleukin-6 as prognosticator in patients with COVID-19

Elisa Grifoni et al.

JOURNAL OF INFECTION (2020)

Review Biochemistry & Molecular Biology

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

Negar Moradian et al.

EUROPEAN CYTOKINE NETWORK (2020)

Article Medicine, General & Internal

Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale

Nosheen Nasir et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Biochemistry & Molecular Biology

COVID-19: immunopathogenesis and Immunotherapeutics

Li Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

The vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response

Maria Wallert et al.

REDOX BIOLOGY (2019)

Article Critical Care Medicine

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

Yaseen M. Arabi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Plant Sciences

Best practice in research: Consensus Statement on Ethnopharmacological Field Studies - ConSEFS

Michael Heinrich et al.

JOURNAL OF ETHNOPHARMACOLOGY (2018)

Article Plant Sciences

Semisynthetic and Natural Garcinoic Acid Isoforms as New mPGES-1 Inhibitors

Khaled Alsabil et al.

PLANTA MEDICA (2016)

Meeting Abstract Biochemistry & Molecular Biology

Regulation of inflammatory pathways by an α-tocopherol long-chain metabolite and a δ-tocotrienol-related natural compound

Schmoelz Lisa et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Review Medicine, General & Internal

SARS: Systematic review of treatment effects

Lauren J. Stockman et al.

PLOS MEDICINE (2006)